John W. Bristol & Co’s Zimmer Biomet ZBH Stock Holding History

John W. Bristol & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,009	Closed	-$202K	–	87
2018 Q4	$202K	Hold	2,009	–	–	0.01%	71
2018 Q3	$256K	Hold	2,009	–	–	0.01%	59
2018 Q2	$217K	Hold	2,009	–	–	0.01%	64
2018 Q1	$213K	Buy	+2,009	New	+$233K	0.01%	67

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

John W. Bristol & Co's ZBH Position: Q1 2019 in Review

John W. Bristol & Co sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 2,009 shares — an estimated $202K sold.

John W. Bristol & Co first reported a position in ZBH in Q1 2018 and held it in 4 quarters. The position peaked at $256K in Q3 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

John W. Bristol & Co reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
John W. Bristol & Co sold 2,009 Zimmer Biomet shares in Q1 2019, an estimated $202K.
John W. Bristol & Co first reported a position in Zimmer Biomet in Q1 2018 and held it in 4 quarters.
John W. Bristol & Co's Zimmer Biomet position peaked at $256K in Q3 2018.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on John W. Bristol & Co's 13F filing for Q1 2019, filed 12 Apr 2019.